Tocilizumab in Severe COVID-19 Disease: Does Timing Matters?

被引：0
|
作者：
Cherrez-Ojeda, I. [1 ]
Vanegas, E. [2 ]
Felix, M. [2 ]
Tovar, M. [3 ]
Bravo, P. [3 ]
Pena, J. [3 ]
Jauregui, J. [3 ]
Silva, D. [3 ]
Bolona, E. [3 ]
机构：
[1] Respiralab, Guayaquil, Ecuador
[2] Univ Espiritu Santo, Samborondon, Ecuador
[3] Clin Guayaquil, Guayaquil, Ecuador
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2653
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Tocilizumab and COVID-19
    Chaudhry, Dhruva
    Singh, Pawan K.
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2020, 24 (09) : 741 - 743
  • [22] Tocilizumab in Covid-19
    Leaf, David E.
    Gupta, Shruti
    Wang, Wei
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (01): : 86 - 87
  • [23] Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?
    Cecilia Söderberg-Nauclér
    Immunity & Ageing, 18
  • [24] Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?
    Soderberg-Naucler, Cecilia
    IMMUNITY & AGEING, 2021, 18 (01)
  • [25] Does timing of tocilizumab administration affect mortality in COVID-19? A Scottish multicentre retrospective cohort study
    MacGregor, Fiona
    Oprey, Alison
    Caulfield, Carolyn
    MacTavish, Pamela
    Lowrie, Richard
    Henderson, Philip
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [26] Baricitinib or Tocilizumab? Treatment of Patients Hospitalized With Severe COVID-19
    Cawcutt, Kelly A.
    Kalil, Andre C.
    CRITICAL CARE MEDICINE, 2023, 51 (03) : 413 - 415
  • [27] Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
    Reid, Nancy Kierstin
    Joyner, Kayla Rena
    Lewis-Wolfson, Temeka Dawn
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (07) : 769 - 775
  • [28] Why tocilizumab could be an effective treatment for severe COVID-19?
    Binqing Fu
    Xiaoling Xu
    Haiming Wei
    Journal of Translational Medicine, 18
  • [29] Tocilizumab in HIV patient with severe COVID-19: case report
    Pedro Vieira Bertozzi
    Amanda de Oliveira Vicente
    Amanda Siqueira Pereira
    Joao Pedro Espinha de Sant’Ana
    Rafaela Braga Cabrera Mano
    Luciana Souza Jorge
    Rodrigo Afonso da Silva Sardenberg
    AIDS Research and Therapy, 18
  • [30] Ruxolitinib for tocilizumab-refractory severe COVID-19 infection
    Innes, Andrew J.
    Cook, Lucy B.
    Marks, Sasha
    Bataillard, Edward
    Crossette-Thambiah, Christina
    Sivasubramaniam, Gayathiri
    Apperley, Jane
    Milojkovic, Dragana
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (04) : E198 - E200
12345